The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas

Lisa M. Stoll, Michael W. Johnson, Edward Gabrielson, Frederic B Askin, Douglas P. Clark, Qing Kay Li

Research output: Contribution to journalArticle

Abstract

Background: New developments in the treatment of lung cancer have necessitated the further histologic and cytologic subtyping of nonsmall cell lung carcinomas. Thyroid transcription factor-1 (TTF-1) long has served as the predominant marker for demonstrating lung origin. However, it is also expressed in a variety of other tumors, particularly neuroendocrine neoplasms and, to a much lesser degree, squamous cell carcinoma of the lung. Napsin-A, which is expressed in lung tissue, is a relatively new marker for lung adenocarcinoma. In this study, the authors examined the utility of napsin-A compared with TTF-1 in cytologic specimens of primary and metastatic, poorly differentiated lung adenocarcinomas. METHODS: The archives of the Department of Pathology at The Johns Hopkins Hospital were searched for cytologic cases of poorly differentiated lung adenocarcinoma that were histologically confirmed. In total, 75 patients (cases) along with 95 controls were included, each of whom had adequate cell block material for TTF-1 and napsin-A staining. Tissue microarrays of lung adenocarcinoma also were examined. RESULTS: TTF-1 and napsin-A were detected in 61 of 75 cases (81.3%) and in 49 of 75 cases (65.3%), respectively. The sensitivity and specificity of TTF-1 were 81% each; and napsin-A had a greater specificity of 96%, and sensitivity of 65%. Napsin-A was not detected in small cell carcinomas or in other carcinomas of nonlung origin except for renal cell carcinoma. CONCLUSIONS: Although TTF-1 had a higher sensitivity, napsin-A was useful as a surrogate marker when encountering a poorly differentiated lung adenocarcinoma or an unknown primary tumor, particularly in cytologic specimens and difficult cases. The current results indicate that the dual use of both markers may be necessary to improve diagnostic accuracy.

Original languageEnglish (US)
Pages (from-to)441-449
Number of pages9
JournalCancer cytopathology
Volume118
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Carcinoma
Lung
Unknown Primary Neoplasms
Sensitivity and Specificity
Small Cell Carcinoma
Neuroendocrine Tumors
Renal Cell Carcinoma
Adenocarcinoma of lung
thyroid nuclear factor 1
Squamous Cell Carcinoma
Lung Neoplasms
Biomarkers
Pathology
Staining and Labeling
Neoplasms
Therapeutics

Keywords

  • Cytology
  • Lung carcinoma
  • Napsin-A
  • Poorly differentiated adenocarcinoma
  • Thyroid transcription factor-1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. / Stoll, Lisa M.; Johnson, Michael W.; Gabrielson, Edward; Askin, Frederic B; Clark, Douglas P.; Li, Qing Kay.

In: Cancer cytopathology, Vol. 118, No. 6, 2010, p. 441-449.

Research output: Contribution to journalArticle

@article{0bc3e2e7d9f84fafbee314c8820a73ae,
title = "The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas",
abstract = "Background: New developments in the treatment of lung cancer have necessitated the further histologic and cytologic subtyping of nonsmall cell lung carcinomas. Thyroid transcription factor-1 (TTF-1) long has served as the predominant marker for demonstrating lung origin. However, it is also expressed in a variety of other tumors, particularly neuroendocrine neoplasms and, to a much lesser degree, squamous cell carcinoma of the lung. Napsin-A, which is expressed in lung tissue, is a relatively new marker for lung adenocarcinoma. In this study, the authors examined the utility of napsin-A compared with TTF-1 in cytologic specimens of primary and metastatic, poorly differentiated lung adenocarcinomas. METHODS: The archives of the Department of Pathology at The Johns Hopkins Hospital were searched for cytologic cases of poorly differentiated lung adenocarcinoma that were histologically confirmed. In total, 75 patients (cases) along with 95 controls were included, each of whom had adequate cell block material for TTF-1 and napsin-A staining. Tissue microarrays of lung adenocarcinoma also were examined. RESULTS: TTF-1 and napsin-A were detected in 61 of 75 cases (81.3{\%}) and in 49 of 75 cases (65.3{\%}), respectively. The sensitivity and specificity of TTF-1 were 81{\%} each; and napsin-A had a greater specificity of 96{\%}, and sensitivity of 65{\%}. Napsin-A was not detected in small cell carcinomas or in other carcinomas of nonlung origin except for renal cell carcinoma. CONCLUSIONS: Although TTF-1 had a higher sensitivity, napsin-A was useful as a surrogate marker when encountering a poorly differentiated lung adenocarcinoma or an unknown primary tumor, particularly in cytologic specimens and difficult cases. The current results indicate that the dual use of both markers may be necessary to improve diagnostic accuracy.",
keywords = "Cytology, Lung carcinoma, Napsin-A, Poorly differentiated adenocarcinoma, Thyroid transcription factor-1",
author = "Stoll, {Lisa M.} and Johnson, {Michael W.} and Edward Gabrielson and Askin, {Frederic B} and Clark, {Douglas P.} and Li, {Qing Kay}",
year = "2010",
doi = "10.1002/cncy.20108",
language = "English (US)",
volume = "118",
pages = "441--449",
journal = "Cancer cytopathology",
issn = "1934-662X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas

AU - Stoll, Lisa M.

AU - Johnson, Michael W.

AU - Gabrielson, Edward

AU - Askin, Frederic B

AU - Clark, Douglas P.

AU - Li, Qing Kay

PY - 2010

Y1 - 2010

N2 - Background: New developments in the treatment of lung cancer have necessitated the further histologic and cytologic subtyping of nonsmall cell lung carcinomas. Thyroid transcription factor-1 (TTF-1) long has served as the predominant marker for demonstrating lung origin. However, it is also expressed in a variety of other tumors, particularly neuroendocrine neoplasms and, to a much lesser degree, squamous cell carcinoma of the lung. Napsin-A, which is expressed in lung tissue, is a relatively new marker for lung adenocarcinoma. In this study, the authors examined the utility of napsin-A compared with TTF-1 in cytologic specimens of primary and metastatic, poorly differentiated lung adenocarcinomas. METHODS: The archives of the Department of Pathology at The Johns Hopkins Hospital were searched for cytologic cases of poorly differentiated lung adenocarcinoma that were histologically confirmed. In total, 75 patients (cases) along with 95 controls were included, each of whom had adequate cell block material for TTF-1 and napsin-A staining. Tissue microarrays of lung adenocarcinoma also were examined. RESULTS: TTF-1 and napsin-A were detected in 61 of 75 cases (81.3%) and in 49 of 75 cases (65.3%), respectively. The sensitivity and specificity of TTF-1 were 81% each; and napsin-A had a greater specificity of 96%, and sensitivity of 65%. Napsin-A was not detected in small cell carcinomas or in other carcinomas of nonlung origin except for renal cell carcinoma. CONCLUSIONS: Although TTF-1 had a higher sensitivity, napsin-A was useful as a surrogate marker when encountering a poorly differentiated lung adenocarcinoma or an unknown primary tumor, particularly in cytologic specimens and difficult cases. The current results indicate that the dual use of both markers may be necessary to improve diagnostic accuracy.

AB - Background: New developments in the treatment of lung cancer have necessitated the further histologic and cytologic subtyping of nonsmall cell lung carcinomas. Thyroid transcription factor-1 (TTF-1) long has served as the predominant marker for demonstrating lung origin. However, it is also expressed in a variety of other tumors, particularly neuroendocrine neoplasms and, to a much lesser degree, squamous cell carcinoma of the lung. Napsin-A, which is expressed in lung tissue, is a relatively new marker for lung adenocarcinoma. In this study, the authors examined the utility of napsin-A compared with TTF-1 in cytologic specimens of primary and metastatic, poorly differentiated lung adenocarcinomas. METHODS: The archives of the Department of Pathology at The Johns Hopkins Hospital were searched for cytologic cases of poorly differentiated lung adenocarcinoma that were histologically confirmed. In total, 75 patients (cases) along with 95 controls were included, each of whom had adequate cell block material for TTF-1 and napsin-A staining. Tissue microarrays of lung adenocarcinoma also were examined. RESULTS: TTF-1 and napsin-A were detected in 61 of 75 cases (81.3%) and in 49 of 75 cases (65.3%), respectively. The sensitivity and specificity of TTF-1 were 81% each; and napsin-A had a greater specificity of 96%, and sensitivity of 65%. Napsin-A was not detected in small cell carcinomas or in other carcinomas of nonlung origin except for renal cell carcinoma. CONCLUSIONS: Although TTF-1 had a higher sensitivity, napsin-A was useful as a surrogate marker when encountering a poorly differentiated lung adenocarcinoma or an unknown primary tumor, particularly in cytologic specimens and difficult cases. The current results indicate that the dual use of both markers may be necessary to improve diagnostic accuracy.

KW - Cytology

KW - Lung carcinoma

KW - Napsin-A

KW - Poorly differentiated adenocarcinoma

KW - Thyroid transcription factor-1

UR - http://www.scopus.com/inward/record.url?scp=79251587670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251587670&partnerID=8YFLogxK

U2 - 10.1002/cncy.20108

DO - 10.1002/cncy.20108

M3 - Article

C2 - 20830690

AN - SCOPUS:79251587670

VL - 118

SP - 441

EP - 449

JO - Cancer cytopathology

JF - Cancer cytopathology

SN - 1934-662X

IS - 6

ER -